Clarke Error Grid
Clarke Error Grid
The Clarke Error Grid is a tool used in diabetes management to assess the accuracy of blood glucose monitoring systems. It was developed by Dr. William Clarke and his colleagues in 1987. The grid is a scatter plot that compares the blood glucose readings from a test device to a reference method, typically a laboratory measurement.
Purpose[edit | edit source]
The primary purpose of the Clarke Error Grid is to evaluate the clinical significance of the differences between the test device readings and the reference method. It helps to determine whether the discrepancies are likely to lead to inappropriate treatment decisions.
Structure[edit | edit source]
The Clarke Error Grid is divided into five zones:
- **Zone A**: Clinically accurate readings that lead to correct treatment decisions.
- **Zone B**: Readings that deviate slightly but would not lead to significant clinical consequences.
- **Zone C**: Readings that could lead to unnecessary treatment.
- **Zone D**: Readings that could lead to a failure to detect and treat a problem.
- **Zone E**: Readings that would result in erroneous treatment decisions.
Clinical Significance[edit | edit source]
The Clarke Error Grid is widely used in the evaluation of glucometers and other blood glucose monitoring devices. It provides a visual and quantitative method to assess the potential impact of measurement errors on patient care. Devices that produce readings predominantly in Zones A and B are considered clinically acceptable.
History[edit | edit source]
The Clarke Error Grid was introduced in a seminal paper published in 1987 by Dr. William Clarke and his team. Since then, it has become a standard tool in the field of diabetes care and has been referenced in numerous studies and guidelines.
Related Tools[edit | edit source]
Other tools similar to the Clarke Error Grid include the Parkes Error Grid and the Consensus Error Grid. These tools also aim to evaluate the accuracy and clinical relevance of blood glucose monitoring systems.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
